Accidente cerebrovascular - revisión de la literatura: etiología, diagnóstico, tratamiento general y análisis pediátrico


PDF ()

Palabras clave

accidente cerebrovascular
ACV
hemoraagia cerebral
hipertención endocraneana
trombosis cerebral
pediatría
rehabilitación

Cómo citar

Álvarez P., A. M. (2016). Accidente cerebrovascular - revisión de la literatura: etiología, diagnóstico, tratamiento general y análisis pediátrico. Revista Colombiana De Enfermería, 6, 102-120. https://doi.org/10.18270/rce.v6i6.1439

Resumen

El accidente cerebro vascular y la trombosis venosa cere - bral son patologías de causa significativa de morbilidad y mortalidad en la población adulta y pediátrica en todo el mundo. La incidencia y prevalencia en los Estados Unidos de América es alta dada la deficiencia en hábitos de vida saludable y alta incidencia de patologías de origen genético (1). La presentación clínica en los pacientes pediátricos es diversa y con representación semiológica distinta a los pacientes adultos. En la práctica médica se debe realizar un enfoque multidisciplinario para el tratamiento de la enfermedad cerebro vascular aguda especialmente en pacientes pediátricos, lo cual permitirá el diagnóstico temprano y la disminución de secuelas (2). Por medio de este artículo explicamos cómo los equipos médicos en medicina de urgencias y los planteamientos en salud pública deben ser evaluados, desarrollados y plasmados en el personal de salud para desarrollar un tratamiento rápido y eficaz en el servicio de urgencias en el diagnóstico temprano, por medio de la aplicación multidisciplinaria del plantel con la identificación y análisis oportunos de signos y síntomas del paciente en cualquier edad (1, 2). Los equipos de emergencia de acci - dente vascular deben estar representados por neurólogos, hematólogos con experiencia en trastornos de la coagu - lación, neuro radiólogos y personal con experiencia en la rehabilitación y servicio de terapia intensivista. Es necesario realizar una gestión integral y oportuna en la capacitación y ejercicio del programa de intervención 

https://doi.org/10.18270/rce.v6i6.1439
PDF ()

Referencias

1. Rey Pérez A. Emergencias neurológicas. Elsevier
España; 2005. pp. 130.
2. Bonduel M, Sciuccati G, Hepner M, Torres AF, Pieroni
G, Frontroth JP. Prethrombotic disorders in children
with arterial ischemic stroke and sinovenous throm
-
bosis. Arch Neurol. 1999; 56: 967–971.
3. Braun KP, Bulder MM, Chabrier S, et ál. The course
and outcome of unilateral intracranial arteriopathy in
79 children with ischaemic stroke. Brain. 2009; 132:
544-557.
4. Lynch JK, Hirtz DG, DeVeber G, et ál. Report of the
National Institute of Neurological Disorders and Stroke
workshop on perinatal and childhood stroke. Pedia
-
trics. 2002; 109: 116-123.
5. Lanthier S, Carmant L, David M, et ál. Stroke in chil
-
dren: the coexistence of multiple risk factors predicts
poor outcome. Neurology. 2000; 54: 371-378.
6. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O’Fallon
WM, Wiebers DO. Ischemic stroke subtypes: a popula
-
tion-based study of incidence and risk factors. Stroke.
1999; 30: 2513–16.
7. Williams LS, Garg BP, Cohen M, Fleck JD, Biller J.
Subtypes of ischemic stroke in children and young
adults. Neurology. 1997; 49: 1541–1545.
8. Garcia JH, Ho Khang-Loon, Pantoni L. Pathology in:
Barnett, Henry JM, Mohr JP, Stein BM, Yatsu FM (eds),
Stroke pathophysiology, diagnosis and management. 3ª
ed. Philadelphia, PA: Churchill Livingston; 1998.
9. Accidente cerebrovascular. Neurowikia febrero 22 2011
[en línea]. Disponible en: content/ictus-en-paciente-joven>.
10. Wise RJ, Bernardi S, Frackowiak RS, Legg NJ, Jones T.
Serial observations on the pathophysiology of acute
stroke: the transition from ischaemia to infarction as
reflected in regional oxygen extraction. Brain. 1983; 106
(Pt 1): 197-222.
11. Pediatric Stroke Working Group. Stroke in childhood:
clinical guidelines for diagnosis, management and
rehabilitation. 2008. Disponible en: rcplondon.ac.uk/pubs/books/childstroke>.
12. Kirkham FJ, Prengler M, Hewes DK, Ganesan V. Risk
factors for arterial ischemic stroke in children. J Child
Neurol. 2000; 15: 299-307.
13. Amlie-Lefond C, Chan AK, Kirton A, et ál. Thrombolysis
in acute childhood stroke: design and challenges of the
thrombolysis in pediatric stroke clinical trial. Neuroepi-
demiology 2009; 32: 279-286.
14. López-Vicente M, Ortega-Gutierrez S, Amlie-Lefond
C, Torbey MT. Diagnosis and menagement of pedi
-
atric arterial ischemic stroke. J Stroke Cerebrovasc Dis.
2010; 19: 175-183.
15. Garcia JH, Liu K, Yoshida Y, et ál. Influx of leukocytes
and platelets in an evolving brain infarct (Wistar rat).
Am J Pathol. 1994; 144: 188-199.
16. Toni D, Fiorelli M, Bastianello S, et ál. Hemorrhagic
transformation of brain infarct: predictability in the
first five hours from stroke onset and influence on clin
-
ical outcome. Neurology. 1996; 46: 341-345.
17. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr. on
Behalf of the American Heart Association Stroke
Council. Expansion of the time window for treatment
of acute ischemic stroke with intravenous tissue plas-
minogen activator. Stroke 2009; 40: 2945–8.
18. Clark WM, Wissman S, Albers GW, Jhamandas JH,
Madden KP, Hamilton S. Recombinant tissue-type plas-
minogen activator (alteplase) for ischemic stroke 3 to 5
hours after symptom onset: the ATLANTIS study—a
randomized controlled trial (alteplase thrombolysis for
acute noninterventional therapy in ischemic stroke).
JAMA 1999; 282: 2019–26.
19. Hacke W, Kaste M, Fieschi C, et ál. Intravenous throm
-
bolysis with recombinant tissue plasminogen activator
for acute hemispheric stroke: the european cooperative
acute stroke study (ECASS). JAMA. 1995; 274: 1017–25.
20. The Internet Stroke Center at Washington University
in St. Louis. Clearer: Study of the combination therapy
of rt-PA and eptifibatide to treat acute ischemic stroke
(SPOTRIAS) [en línea] [Consultado en diciembre de
2009]. Disponible en: trials/TrialDetail.aspx?tid=995>.
21. The IMS Study Investigators. Combined intravenous
and intraarterial recanalization for acute ischemic
stroke: the interventional management of stroke study.
Stroke. 2004; 35: 904–11.
22. The IMS II Trial Investigators. The interventional
management of stroke (IMS) II study. Stroke. 2007; 38:
2127–35.
23. Gladstone DJ, Black SE, Hakim AM. Toward wisdom
from failure: lessons from neuroprotective stroke trials
and new therapeutic directions. Stroke. 2002; 33: 2123–
36.
24. Saver JL, Kidwell C, Eckstein M, Starkman S. Prehos-
pital neuroprotective therapy for acute stroke: results of
the field administration of stroke therapy– magnesium
(FAST-MAG) pilot trial. Stroke. 2004; 35: e106–8.
25. Elkind MS, Flint AC, Sciacca RR, Sacco RL. Lipid-
lowering agent use at ischemic stroke onset is
associated with decreased mortality. Neurology. 2005;
65: 253–8.
26. Laskowitz DT, Kasner SE, Saver J, Remmel KS, Jauch
EC. Clinical usefulness of a biomarker-based diagnostic
test for acute stroke: the biomarker rapid assessment
in ischemic injury (BRAIN) study. Stroke. 2009; 40:
77–85.
27. Polderman KH, Herold I. Therapeutic hypothermia
and controlled normothermia in the intensive care
unit: practical considerations, side effects, and cooling
methods. Crit Care Med 2009; 37: 1101–20.
28. Challa V. Atherosclerosis of the cervicocranial arteries.
In: Toole JF, ed. Cerebrovascular disorders. 5ª ed. Phila
-
delphia: Lippincott Williams and Wilkins; 1999.
29. Fuster V. Stein B, Amboose JA, et ál. Atherosclerotic
plaque rupture and thrombosis: evolving concepts.
Circulation. 1990; 82 (supp II); 47-59.
30. Glaglov S, Zarins CB. What are the determinants of
plaque instability and its consequences? J Vasc Surg.
198; 9: 389-390. Pathophysiology of Stroke Page 11 of
14 Sid Shah, MD.
31. Falk E. Why do plaques rupture? Circulation. 1992; 86:
30-42.
32. Zamir M, Silver MD. Hemorrhagic and mocrovascular
phenomenon within the arterial wall. Can J Cardiol.
1992; 8: 981-84.
33. Pullicino PM. Pathogenesis of lacunar infarcts and
small deep infarcts. Adv Neurol. 1993; 62: 125-140.
34. Graf R, Saito R, Hubel K, et ál. Spreading depression-
like negativations turn into terminal depolarizations
after prolonged focal ischemia in rates. J Cereb Blood
Flow Metab. 1995; 15 (supp 1): S15.
35. Rankel MR, et ál. Predicting prognosis after stroke. A
placebo group analysis from the National Institute of
Neurological Disorders and Stroke rt-PAstroke trial.
Neurology. 2000; 55: 952-9.
36. Blanco M, Nombela F, Castellanos M, et ál. Statin
treatment withdrawal in ischemic stroke: a controlled
randomized study. Neurology. 2007; 69: 904–10.
37. Kirkham FJ, Lerner NB, Noetzel M, et ál. Trials in sickle
cell disease. Pediatr Neurol 2006; 34: 450-458.
38. Pediatric Stroke Working Group. Stroke in childhood:
clinical guidelines for diagnosis, management and
rehabilitation, 2004 [en línea] [consultado en febrero
de 2011]. Disponible en: pubs/books/childstroke>.
39. Heros R. Stroke: early pathophysiology and treatment.
Stroke. 1994; 25: 1877-1881.
40. Siesjő BK. Cell damage in the brain: a speculative
synthesis. J Cereb Blood Flow Metab. 1981; 1: 115-185.
41. Roach ES, Golomb MR, Adams R, et ál. Management
of stroke in infants and children: a scientific state
-
ment from a Special Writing Group of the American
Heart Association Stroke Council and the Council on
Cardiovascular Disease in the Young.American Heart
Association Stroke Council; Council on Cardiovascular
Disease in the Young.Stroke. 2009; 40: e8-10.
42. Garcia JH, Liu K, Yoshida Y, et ál. Brain mictrovessels:
factors altering their patency after the occlusion of a
middle cerebral artery (Wistar rat). Am J Pathol.1994;
145: 728-40.
43. Expert Panel on Detection, Evaluation and Treatment of
High Blood Cholesterol in Adults. Executive summary
of the third report of the national cholesterol education
program (NCEP) expert panel on detection, evaluation,
and treatment of high blood cholesterol in adults (adult
treatment panel III). JAMA.2001; 285: 2486–97.
44. Angelini L, Ravelli A, Caporali R, Rumi V, Nardocci N,
Martini A. High prevalence of antiphospholipid anti
-
bodies in children with idiopathic cerebral ischemia.
Pediatrics. 1994; 94: 500–503.
45. Ware RE, Zimmerman SA, Sylvestre PB, et ál. Preven
-
tion of secondary stroke and resolution of transfusional
iron overload in children with sickle cell anemia using
hydroxyurea and phlebotomy. J Pediatr.2004; 145:
346-352.
46. Hansen AJ. Effects of anoxia on ion distribution in the
brain. Physiol Rev. 1985; 65: 101-148.
47. Golomb MR, MacGregor DL, Domi T, et ál. Presumed
pre-or perinatal arterial ischemic stroke: risk factors
and outcomes.Ann Neurol. 2001; 50: 163–168.
48. Schwab S, Spranger M, Aschoff A, et ál. Brain tempera
-
ture monitoring and modulation in patients with severe
MCA infarction. Neurology.1997; 48: 762-767.
49. Pulsinelli WA. The ischemic penumbra in stroke. Sci
Med. 1995; 1: 16-25.
50. DeVeber G, MacGregor D, Curtis R, Mayank S. Neuro
-
logic outcome in survivors of childhood arterial
ischemic stroke and sinovenous thrombosis. J Child
Neurol. 2000; 15: 316–324.
51. DeVeber G, Andrew M. Cerebral sinovenous throm
-
bosis in children. N Engl J Med. 2001; 345: 417–423.
52. Alberts MJ, Latchaw RE, Selman WR, et ál. Recommen
-
dations for comprehensive stroke centers: a consensus
statement from the brain attack coalition. Stroke. 2005;
36: 1597–616.
53. Macgregor D, Shroff M. Presumed perinatal ischemic
stroke: vascular classification predicts outcomes.
Annals of Neurology, 2008; 63: 436–443.
54. Broderick J, Brott T, Kothari R, et ál. The Greater Cincin
-
nati/Northern Kentucky Stroke Study. Preliminary
first-ever and total incidence rates of stroke among
blacks. Stroke.1998; 29: 415–421.
55. Fullerton HJ, Wu YW, Sidney S, et ál. Risk of recurrent
childhood arterial ischemic stroke in a population-
based cohort: The importance of cerebrovascular
imaging. Pediatrics. 2007; 119: 495-501.
56. Gosalakkal JA. Moyamoya disease: a review. Neurol
India 2002; 50: 6-10.
57. Husson B, Rodesch G, Lasjaunias P, et ál. Magnetic
resonance angiography in childhood arterial brain
infarcts: a comparative study with contrast angiog
-
raphy. Stroke. 2002; 33: 1280-1285.
58. Hunt WE, Hess RM. Surgical risk as related to time of
intervention in the repair of intracranial aneurysms. J
Neurosurg.1968; 28: 14-20.
59. Keun-Sik MD, Jeffrey L, et ál. Quantifying the value of
stroke disability outcomes. Stroke. 2009; 40: 3828-33.
60. Linfante I, et ál. Diffusion-weighted imaging and
National Institutes of Health Stroke Scale in the acute
phase of posterior circulation stroke. Arch Neurol.
2001; 58: 621-8.
61. Mahoney FI, Barthel DW. Functional evaluation: the
Barthel Index. Med J. 1965: 13: 61-65.
62. Takagi K, Ginsberg MD, Globus MY-T, et ál. Changes in
amino acid neurotransmitters and cerebral blood flow
in the ischemic penumbral region following middle
cerebral artery occlusion in the rat: correlation with
histopathology. J Cereb Blood Flow Metab. 1993; 13:
575-585.
63. Back T, Ginsberg MD, Dietrich WD, Watson BD.
Induction of spreading depression in the ischemic
hemisphere following experimental middle cerebral
artery occlusion: effect on infarct morphology. J Cereb
Blood Flow Metab. 1996; 16: 202-213.
64. Vahedi K, Hofmeijer J, Juettler E, et ál. Early decom
-
pressive surgery in malignant infarction of the middle
cerebral artery: a pooled analysis of three randomised
controlled trials. Lancet Neurol. 2007; 6: 215–22.
65. Mayer SA, Rincon F. Treatment of intracerebral hemor
-
rhage. Lancet Neurol 2005; 4: 662–72.
66. The Internet Stroke Center at Washington University in
St. Louis.Stroke interventions in clinical trials: Investi
-
gational drugs—by name [en línea] [consultado el 6 de
marzo de 2011]. Disponible en: -
center.org/Trials/index_drugs.aspx>.
67. Saver JL, Albers GW, Dunn B, Johnston KC, Fisher M.
Stroke therapy academic industry roundtable (STAIR)
recommendations for extended window acute stroke
therapy trials. Stroke. 2009; 40: 2594–600.
68. Specialized Programs of Translational Research in
Acute Stroke (SPOTRIAS) Network [en línea] [consul
-
tado el 6 de marzo de 2010].Disponible en: hopecenter.wustl.edu/spotrias/Pages/default.aspx>.
69. Wass CT, Lanier WL. Glucose modulation of ischemic
brain injury: review and clinical recommendations.
Mayo Clin Proc. 1996; 71: 801-812.
70. Bardutzky J, Schwab S. Antiedema therapy in ischemic
stroke. Stroke.2007; 38: 3084–94.
71. Atkinson DS Jr. Computered tomography of pediatric
stroke. Semin Ultrasound CT MRT.2006; 27: 207-218.
72. Kim CY, Wang KC, Kim SK, et ál. Encephaloduroarterio
-
synangiosis with bifrontal encephalogaleo (periosteal)
- synangiosis in the pediatric moyamoya disease: the
surgical technique and its outcomes. Childs Nerv Syst.
2003; 19: 316-324.
73. Lynch JK. Cerebrovascular disorders in children. Curr
Neurol Neurosci Rep. 2004; 4: 129-138.
74. Roach ES, Golomb MR, Adams R, et ál. Management
of stroke in infants and children: a scientific state
-
ment from a special writing group of the American
Heart Association stroke council and the council on
cardiovascular disease in the young. Stroke. 2008; 39:
2644–91.
75. Gruber A. Interventional management of stroke. Stroke.
2008; 39: 1663–4.
76. National Institute of Neurological Disorders and
Stroke.NINDS CADASIL (cerebral autosomal dominant
arteriopathy with subcortical infarcts and Leukoen
-
cephalopathy) [en línea] [consultado en marzo de 2010].
Disponible en: cadasil/CADASIL.htm>.
77. Hacke W, Kaste M, Bluhmki E, et ál for the ECASS
Investigators. Thrombolysis with alteplase 3 to 4.5
hours after acute ischemic stroke.N Engl J Med. 2008;
359: 1317–29.
78. Foerch C, Montaner J, Furie KL, Ning MM, Lo EH.Invited
article: Searching for oracles? Blood biomarkers in
acute stroke. Neurology. 2009; 73: 393–9.
79. Reith J, Jorgensen HS, Pedersen PM, et ál. Body
temperature in acute stroke: relation to stroke severity,
infarct size, mortality and outcome. Lancet. 1996; 347:
422-425.
80. Bruno A, Biller J, Adams HP Jr, et ál. Acute blood glucose
level and outcome from ischemic stroke. Neurology.
1999; 52: 280-284.
81. Astrup J, Seisjo BK, Symon L. Thresholds in cerebral
ischemia – the ischemic penumbra. Stroke. 1981; 12:
723-725.
82. Pezzini A, Del Zotto E, Giossi A, Volonghi I, Grassi M,
Padovani A. The migraine–ischemic stroke connec
-
tion: potential pathogenic mechanisms. Curr Mol Med.
2009; 9: 215–26.
83. Price DJ. Factors restricting the use of coma scales.
Acta Neuro-chir. 1986; 36 (suppl.): 106-111.
84. Stammt JE, Lindffen S. ls it posible to define a general
conscious level? Acta Neurochir. 1986; 36 (suppl.):
103-105.
85. Heinemman AW, Harvey RL, McGuire JR, et ál. Measure
-
ment properties of the NIH Stroke Scale during acute
rehabilitation. Stroke. 1997; 28: 1174-80.
86. Teasdale G, Jennett B. Assessment of coma and
impaired consciousness. A practical scale. Lancet.
1974; 2: 81-84.
87. Saver JL, Gornbein J, Grotta J, et ál. Number needed to
treat to benefit and to harm for intravenous tissue plas
-
minogen activator therapy in the 3 to 4.5 hour window:
joint outcome table analysis of the ECASS 3 trial. Stroke.
2009; 40: 2433–7
88. Lyden PD, Allgren RL, Ng K, et ál. Intravascular cooling
in the treatment of stroke (ICTuS): early clinical
experience.J Stroke Cerebrovasc Dis. 2005; 14: 107–14.
89. Wahlgren N, Ahmed N, Davalos A, et ál. Thrombolysis
with alteplase 3–4.5 h after acute ischaemic stroke
(SITS-ISTR): an observational study. Lancet. 2008; 372:
1303–9.
90. Zaidat OO, Klucznik R, Alexander MJ. The NIH registry
on use of the Wingspan stent for symptomatic 70–99%
intracranial arterial stenosis. Neurology. 2008;70:
1518–24.
91. Paciaroni M, Agnelli G, Corea F, et ál. Early hemorrhagic
transformation of brain infarction: rate, predictive
factors and influence on clinical outcome— Results
of a prospective multicenter study. Stroke. 2008; 39:
2249–56.
92. Bershad EM, Feen ES, Hernandez OH, Suri MF, Suarez
JI.Impact of a specialized neurointensive care team on
outcomes of critically ill acute ischemicstroke patients.
Neurocrit Care. 2008; 9: 287–92.
93. Caplan LR. Resolved: heparin may be useful in selected
patients with brain ischemia. Stroke. 2003; 34: 230–1.
94. Chamorro A, Vila N, Ascaso C, Blanc R. Heparin in
acute stroke with atrial fibrillation: clinical relevance of
very early treatment. Arch Neurol. 1999; 56: 1098–102.
95. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P.
Antithrombotic and thrombolytic therapy for ischemic
stroke: American College of Chest Physicians evidence-
based clinical practice guidelines, 8th ed. Chest. 2008;
133(6 suppl): S630–69.
96. Demaerschalk BM, Miley ML, Kiernan TE, et ál. Stroke
telemedicine. Mayo Clin Proc. 2009; 84: 53–64.
97. Dambinova SA, Khounteev GA, Izykenova GA, Zavo
-
lokov IG, Ilyukhina AY, Skoromets AA. Blood test
detecting autoantibodies to N-methyl-D-aspartate
neuroreceptors for evaluation of patients with tran
-
sient ischemic attack and stroke. Clin Chem. 2003; 49:
1752–62.
98. Guías Americanas Stroke e Hipertensión Arterial[en
línea] [consultado en marzo de 2011]. Disponible
en: jhtml?identifier=4742>.
99. Centers for Disease Control and Prevention. Prehos
-
pital and hospital delays after stroke onset—United
States, 2005–2006.MMWR Morb Mortal Wkly Rep.
2007; 56: 474–8.
100.
Lamonte MP, Bahouth MN, Magder LS, et ál. A
regional system of stroke care provides thrombolytic
outcomes comparable with the NINDS stroke trial.
Ann Emerg Med. 2009; 54: 319–27.
101. The Internet Stroke Center at Washington University
in St. Louis.Stroke scales and clinical assessment
tools [en línea] [consultado en octubre de 2010].
Disponible en: < http: //www.strokecenter.org/trials/
scales/index.htm>.
102.
Montaner J, Álvarez-Sabin J. NIH Stroke Scale and
its adaptation to Spanish. Neurología. 2006; 21(4):
192-202.
103. Broderick J, Connolly S, Feldmann E, et ál. Guidelines
for the management of spontaneous intracerebral
hemorrhage in adults: 2007 update— A guideline
from the American Heart Association/American
Stroke Association stroke council, high blood pres-
sure research council, and the quality of care and
outcomes in research interdisciplinary working
group. Circulation. 2007;116: e391–413.
104.
Potter JF, Robinson TG, Ford GA, et ál. Controlling
hypertension and hypotension immediately post-
stroke (CHHIPS): a randomised, placebocontrolled,
double-blind pilot trial. Lancet Neurol. 2009; 8: 48–56.
105. Accidente cerebro vascular, generalidades y rehabili
-
tación [en línea] [consultado en noviembre de 2010].
Disponible en: introducci%C3%B3n-al-ictus-en-edadpedi%C3%A1

Para preservar los derechos de autor, todos los documentos publicados en la Revista Colombiana de Enfermería incluirán todos los autores según el orden definido por ellos mismos. Además, los autores, como titulares de los derechos patrimoniales de autor, deberán autorizar la reproducción y puesta a disposición indefinida del texto, figuras o cualquier otro material del artículo, a nivel nacional o internacional, por el máximo tiempo legal, tanto en medio impreso como electrónico (en papel, internet, CD u otros) y en las demás actividades que la Revista Colombiana de Enfermería considere pertinentes. La revista, por ser de acceso abierto, permite la consulta, lectura, copia, impresión, descargue, distribución y exhibición de los textos completos de sus artículos en su versión en línea sin costo alguno para los usuarios, siempre y cuando se dé testimonio de la autoría del mismo y no se busque la obtención de beneficios comerciales por parte de terceros. Esta revista provee acceso libre inmediato a su contenido bajo el principio de que hacer disponible gratuitamente la investigación al público fomenta un mayor intercambio de conocimiento global.

Los artículos se publicarán bajo una licencia Creative Commons Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0) la cual permite compartir, copiar y redistribuir el material en cualquier medio o formato siempre y cuando: se dé crédito de manera adecuada, brinde un enlace a la licencia e indique si se han realizado cambios; no se use el contenido con propósitos comerciales; y no se remezcle o transforme el material.

Ni la Revista ni la Universidad asumen la responsabilidad de las opiniones expresadas por los autores. El uso de los nombres de todos los equipos, materiales y productos manufacturados (incluidos los medicamentos que pueden mencionarse) no implica que la revista publicite o promueva su uso; solo se mencionan como una identificación general.

Descargas

La descarga de datos todavía no está disponible.